Your shopping cart is currently empty

TNIK-IN-9 (Compound 54) is a selective and potent NIK inhibitor with an IC50 of 1.27 nM. It effectively suppresses the production of pro-inflammatory cytokines and nitric oxide. In sepsis models, TNIK-IN-9 demonstrates significant anti-inflammatory effects, reduces mortality, and provides liver protection.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | TNIK-IN-9 (Compound 54) is a selective and potent NIK inhibitor with an IC50 of 1.27 nM. It effectively suppresses the production of pro-inflammatory cytokines and nitric oxide. In sepsis models, TNIK-IN-9 demonstrates significant anti-inflammatory effects, reduces mortality, and provides liver protection. |
| In vitro | TNIK-IN-9 (5 μM, 2 h) reduces the levels of inflammatory cytokines and chemokines (TNF-α, IL-6, IL-1β, and CCL12, respectively) in RAW264.7 cells induced by LPS and CD40. |
| In vivo | TNIK-IN-9 (10 mg/kg, intraperitoneal injection, single dose) suppresses the secretion of inflammatory cytokines (TNF-α, IL-1β, CXCL-12, IL-6, IFN-γ) induced by LPS in mice. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.